Cantaloupe (USAT) Competitors

$11.20 +0.01 (+0.09%)

As of 05/5/2026

USAT vs. KLRA, QTEC, ANGL, PRFZ, and FTGC

Should you be buying Cantaloupe stock or one of its competitors? The main competitors of Cantaloupe include Kailera Therapeutics (KLRA), First Trust NASDAQ-100 Technology Sector Index Fund (QTEC), VanEck Fallen Angel High Yield Bond ETF (ANGL), Invesco RAFI US 1500 Small-Mid ETF (PRFZ), and First Trust Global Tactical Commodity Strategy Fund (FTGC). These companies are all part of the "manufacturing" sector.

How does Cantaloupe compare to Kailera Therapeutics?

Kailera Therapeutics (NASDAQ:KLRA) and Cantaloupe (NASDAQ:USAT) are both manufacturing companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

: In the previous week, Kailera Therapeutics had 2 more articles in the media than Cantaloupe. MarketBeat recorded 2 mentions for Kailera Therapeutics and 0 mentions for Cantaloupe. Kailera Therapeutics' average media sentiment score of 0.00 equaled Cantaloupe'saverage media sentiment score.
Company Overall Sentiment
Kailera Therapeutics Neutral
Cantaloupe Neutral
: Kailera Therapeutics has higher earnings, but lower revenue than Cantaloupe.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Kailera Therapeutics N/A N/A N/A N/A N/A
Cantaloupe $150.91M 5.28 -$34.12M -$0.48 N/A
: 61.6% of Cantaloupe shares are held by institutional investors. 18.8% of Cantaloupe shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: Company Net Margins Return on Equity Return on Assets
Kailera Therapeutics N/A N/A N/A
Cantaloupe N/A N/A N/A

Company	Overall Sentiment
Kailera Therapeutics	Neutral
Cantaloupe	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kailera Therapeutics	N/A	N/A	N/A	N/A	N/A
Cantaloupe	$150.91M	5.28	-$34.12M	-$0.48	N/A

Company	Net Margins	Return on Equity	Return on Assets
Kailera Therapeutics	N/A	N/A	N/A
Cantaloupe	N/A	N/A	N/A

Summary

Cantaloupe beats Kailera Therapeutics on 3 of the 4 factors compared between the two stocks.

How does Cantaloupe compare to First Trust NASDAQ-100 Technology Sector Index Fund?

First Trust NASDAQ-100 Technology Sector Index Fund (NASDAQ:QTEC) and Cantaloupe (NASDAQ:USAT) are both manufacturing companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.

: First Trust NASDAQ-100 Technology Sector Index Fund currently has a consensus price target of $285.77, indicating a potential upside of 0.00%. Given First Trust NASDAQ-100 Technology Sector Index Fund's stronger consensus rating and higher probable upside, analysts plainly believe First Trust NASDAQ-100 Technology Sector Index Fund is more favorable than Cantaloupe.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
First Trust NASDAQ-100 Technology Sector Index Fund
0 Sell rating(s)
4 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.74
Cantaloupe
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: First Trust NASDAQ-100 Technology Sector Index Fund has higher earnings, but lower revenue than Cantaloupe.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
First Trust NASDAQ-100 Technology Sector Index Fund N/A N/A N/A N/A N/A
Cantaloupe $150.91M 5.28 -$34.12M -$0.48 N/A
: In the previous week, First Trust NASDAQ-100 Technology Sector Index Fund had 1 more articles in the media than Cantaloupe. MarketBeat recorded 1 mentions for First Trust NASDAQ-100 Technology Sector Index Fund and 0 mentions for Cantaloupe. First Trust NASDAQ-100 Technology Sector Index Fund's average media sentiment score of 1.58 beat Cantaloupe's score of 0.00 indicating that First Trust NASDAQ-100 Technology Sector Index Fund is being referred to more favorably in the media.
Company Overall Sentiment
First Trust NASDAQ-100 Technology Sector Index Fund Very Positive
Cantaloupe Neutral
: 61.6% of Cantaloupe shares are held by institutional investors. 18.8% of Cantaloupe shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
: Company Net Margins Return on Equity Return on Assets
First Trust NASDAQ-100 Technology Sector Index Fund N/A N/A N/A
Cantaloupe N/A N/A N/A
: First Trust NASDAQ-100 Technology Sector Index Fund has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Comparatively, Cantaloupe has a beta of 2.25, suggesting that its share price is 125% more volatile than the S&P 500.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
First Trust NASDAQ-100 Technology Sector Index Fund	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.74
Cantaloupe	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
First Trust NASDAQ-100 Technology Sector Index Fund	N/A	N/A	N/A	N/A	N/A
Cantaloupe	$150.91M	5.28	-$34.12M	-$0.48	N/A

Company	Overall Sentiment
First Trust NASDAQ-100 Technology Sector Index Fund	Very Positive
Cantaloupe	Neutral

Company	Net Margins	Return on Equity	Return on Assets
First Trust NASDAQ-100 Technology Sector Index Fund	N/A	N/A	N/A
Cantaloupe	N/A	N/A	N/A

Summary

First Trust NASDAQ-100 Technology Sector Index Fund beats Cantaloupe on 6 of the 10 factors compared between the two stocks.

How does Cantaloupe compare to VanEck Fallen Angel High Yield Bond ETF?

VanEck Fallen Angel High Yield Bond ETF (NASDAQ:ANGL) and Cantaloupe (NASDAQ:USAT) are both manufacturing companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

: VanEck Fallen Angel High Yield Bond ETF has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500. Comparatively, Cantaloupe has a beta of 2.25, meaning that its share price is 125% more volatile than the S&P 500.
: Company Net Margins Return on Equity Return on Assets
VanEck Fallen Angel High Yield Bond ETF N/A N/A N/A
Cantaloupe N/A N/A N/A
: VanEck Fallen Angel High Yield Bond ETF has higher earnings, but lower revenue than Cantaloupe.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
VanEck Fallen Angel High Yield Bond ETF N/A N/A N/A N/A N/A
Cantaloupe $150.91M 5.28 -$34.12M -$0.48 N/A
: In the previous week, VanEck Fallen Angel High Yield Bond ETF had 2 more articles in the media than Cantaloupe. MarketBeat recorded 2 mentions for VanEck Fallen Angel High Yield Bond ETF and 0 mentions for Cantaloupe. VanEck Fallen Angel High Yield Bond ETF's average media sentiment score of 0.14 beat Cantaloupe's score of 0.00 indicating that VanEck Fallen Angel High Yield Bond ETF is being referred to more favorably in the media.
Company Overall Sentiment
VanEck Fallen Angel High Yield Bond ETF Neutral
Cantaloupe Neutral
: 61.6% of Cantaloupe shares are owned by institutional investors. 18.8% of Cantaloupe shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
VanEck Fallen Angel High Yield Bond ETF	N/A	N/A	N/A
Cantaloupe	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VanEck Fallen Angel High Yield Bond ETF	N/A	N/A	N/A	N/A	N/A
Cantaloupe	$150.91M	5.28	-$34.12M	-$0.48	N/A

Company	Overall Sentiment
VanEck Fallen Angel High Yield Bond ETF	Neutral
Cantaloupe	Neutral

Summary

Cantaloupe beats VanEck Fallen Angel High Yield Bond ETF on 4 of the 7 factors compared between the two stocks.

How does Cantaloupe compare to Invesco RAFI US 1500 Small-Mid ETF?

Cantaloupe (NASDAQ:USAT) and Invesco RAFI US 1500 Small-Mid ETF (NASDAQ:PRFZ) are both manufacturing companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

: 61.6% of Cantaloupe shares are owned by institutional investors. 18.8% of Cantaloupe shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
: Company Net Margins Return on Equity Return on Assets
Cantaloupe N/A N/A N/A
Invesco RAFI US 1500 Small-Mid ETF N/A N/A N/A
: Invesco RAFI US 1500 Small-Mid ETF has lower revenue, but higher earnings than Cantaloupe.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cantaloupe $150.91M 5.28 -$34.12M -$0.48 N/A
Invesco RAFI US 1500 Small-Mid ETF N/A N/A N/A N/A N/A
: Invesco RAFI US 1500 Small-Mid ETF has a consensus price target of $51.09, suggesting a potential upside of 0.00%. Given Invesco RAFI US 1500 Small-Mid ETF's stronger consensus rating and higher probable upside, analysts plainly believe Invesco RAFI US 1500 Small-Mid ETF is more favorable than Cantaloupe.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cantaloupe
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Invesco RAFI US 1500 Small-Mid ETF
0 Sell rating(s)

7 Hold rating(s)

3 Buy rating(s)

0 Strong Buy rating(s)
2.55
: Cantaloupe has a beta of 2.25, meaning that its stock price is 125% more volatile than the S&P 500. Comparatively, Invesco RAFI US 1500 Small-Mid ETF has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500.
: In the previous week, Cantaloupe's average media sentiment score of 0.00 equaled Invesco RAFI US 1500 Small-Mid ETF'saverage media sentiment score.
Company Overall Sentiment
Cantaloupe Neutral
Invesco RAFI US 1500 Small-Mid ETF Neutral

Company	Net Margins	Return on Equity	Return on Assets
Cantaloupe	N/A	N/A	N/A
Invesco RAFI US 1500 Small-Mid ETF	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cantaloupe	$150.91M	5.28	-$34.12M	-$0.48	N/A
Invesco RAFI US 1500 Small-Mid ETF	N/A	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cantaloupe	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Invesco RAFI US 1500 Small-Mid ETF	0 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.55

Company	Overall Sentiment
Cantaloupe	Neutral
Invesco RAFI US 1500 Small-Mid ETF	Neutral

Summary

Cantaloupe and Invesco RAFI US 1500 Small-Mid ETF tied by winning 4 of the 8 factors compared between the two stocks.

How does Cantaloupe compare to First Trust Global Tactical Commodity Strategy Fund?

First Trust Global Tactical Commodity Strategy Fund (NASDAQ:FTGC) and Cantaloupe (NASDAQ:USAT) are both manufacturing companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

: 61.6% of Cantaloupe shares are held by institutional investors. 18.0% of First Trust Global Tactical Commodity Strategy Fund shares are held by company insiders. Comparatively, 18.8% of Cantaloupe shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: First Trust Global Tactical Commodity Strategy Fund has a beta of 0.14, meaning that its stock price is 86% less volatile than the S&P 500. Comparatively, Cantaloupe has a beta of 2.25, meaning that its stock price is 125% more volatile than the S&P 500.
: Company Net Margins Return on Equity Return on Assets
First Trust Global Tactical Commodity Strategy Fund N/A N/A N/A
Cantaloupe N/A N/A N/A
: In the previous week, First Trust Global Tactical Commodity Strategy Fund had 5 more articles in the media than Cantaloupe. MarketBeat recorded 5 mentions for First Trust Global Tactical Commodity Strategy Fund and 0 mentions for Cantaloupe. First Trust Global Tactical Commodity Strategy Fund's average media sentiment score of 1.01 beat Cantaloupe's score of 0.00 indicating that First Trust Global Tactical Commodity Strategy Fund is being referred to more favorably in the media.
Company Overall Sentiment
First Trust Global Tactical Commodity Strategy Fund Positive
Cantaloupe Neutral
: First Trust Global Tactical Commodity Strategy Fund has higher earnings, but lower revenue than Cantaloupe.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
First Trust Global Tactical Commodity Strategy Fund N/A N/A N/A N/A N/A
Cantaloupe $150.91M 5.28 -$34.12M -$0.48 N/A

Company	Net Margins	Return on Equity	Return on Assets
First Trust Global Tactical Commodity Strategy Fund	N/A	N/A	N/A
Cantaloupe	N/A	N/A	N/A

Company	Overall Sentiment
First Trust Global Tactical Commodity Strategy Fund	Positive
Cantaloupe	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
First Trust Global Tactical Commodity Strategy Fund	N/A	N/A	N/A	N/A	N/A
Cantaloupe	$150.91M	5.28	-$34.12M	-$0.48	N/A

Summary

Cantaloupe beats First Trust Global Tactical Commodity Strategy Fund on 4 of the 6 factors compared between the two stocks.

Get Cantaloupe News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding USAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

USAT vs. The Competition

Export

Metric	Cantaloupe	Computer Storage Device Manufacturing Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$796.09M	$796.09M	$4.24B	$12.15B
Dividend Yield	N/A	N/A	5.93%	5.25%
P/E Ratio	-23.33	N/A	23.62	27.01
Price / Sales	5.28	5.28	162.14	76.85
Price / Cash	N/A	N/A	52.59	53.97
Price / Book	N/A	N/A	42.56	6.89
Net Income	-$34.12M	N/A	$114.66M	$333.11M
7 Day Performance	N/A	N/A	-1.12%	0.14%
1 Month Performance	4.19%	4.19%	4.29%	6.79%
1 Year Performance	36.25%	36.25%	19.43%	38.93%

Cantaloupe Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
USAT Cantaloupe	N/A	$11.20 +0.1%	N/A	+37.3%	$796.09M	$150.91M	N/A	N/A	High Trading Volume
KLRA Kailera Therapeutics	N/A	$24.76 +3.9%	N/A	N/A	$3.06B	N/A	N/A	145
QTEC First Trust NASDAQ-100 Technology Sector Index Fund	N/A	$262.34 +2.2%	N/A	+57.2%	$3.06B	N/A	35.79	147,000	Positive News
ANGL VanEck Fallen Angel High Yield Bond ETF	N/A	$29.17 -0.3%	N/A	+2.9%	$3.04B	N/A	59.37	147,000
PRFZ Invesco RAFI US 1500 Small-Mid ETF	N/A	$49.62 -0.8%	N/A	+36.2%	$2.82B	N/A	18.02	147,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:USAT) was last updated on 5/8/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cantaloupe (USAT) Competitors

USAT vs. KLRA, QTEC, ANGL, PRFZ, and FTGC

How does Cantaloupe compare to Kailera Therapeutics?

Summary

How does Cantaloupe compare to First Trust NASDAQ-100 Technology Sector Index Fund?

Summary

How does Cantaloupe compare to VanEck Fallen Angel High Yield Bond ETF?

Summary

How does Cantaloupe compare to Invesco RAFI US 1500 Small-Mid ETF?

Summary

How does Cantaloupe compare to First Trust Global Tactical Commodity Strategy Fund?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USAT vs. The Competition

Cantaloupe Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cantaloupe (USAT) Competitors

USAT vs. KLRA, QTEC, ANGL, PRFZ, and FTGC

How does Cantaloupe compare to Kailera Therapeutics?

Summary

How does Cantaloupe compare to First Trust NASDAQ-100 Technology Sector Index Fund?

Summary

How does Cantaloupe compare to VanEck Fallen Angel High Yield Bond ETF?

Summary

How does Cantaloupe compare to Invesco RAFI US 1500 Small-Mid ETF?

Summary

How does Cantaloupe compare to First Trust Global Tactical Commodity Strategy Fund?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USAT vs. The Competition

Cantaloupe Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools